IMV, Inc.

IMV, Inc.

IMV, Inc.

Overview
Date Founded

2007

Headquarters

130 Eileen Stubbs Avenue, Suite 19, Dartmouth, NS, B3B 2C4, CAN

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Biotechnology
IT Consulting & Services
Pharmaceuticals
Medical Support Services

Company Description

IMV, Inc. is a clinical-stage biopharmaceutical company that engages in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities. Its drug candidate, DPX-Survivac, is a targeted T cell therapy that has completed multiple phases 1 and 1b trials generating results in late-stage ovarian cancer and relapsed/refractory DLBCL (Diffuse Large B Cell Lymphoma) where it has identified a predictive biomarker. The company was founded by Warwick Kimmins and Brian E. Lowe on May 18, 2007 and is headquartered in Dartmouth, Canada.

Contact Data
Trying to get in touch with decision makers at IMV, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Interim Chief Executive Officer

Chief Financial Officer

Chief Scientific Officer

Senior Director of Quality

Director of Quality Assurance

Vice President, Clinical Research

Executive Chairman

Senior Director-Investor Relations

Vice President, Human Resources

Vice President-Clinical Research

Board of Directors

Chief Executive Officer, President at Medicago USA, Inc.

Former Executive Chairman at Cavion, Inc.

Venture Partner at Versant Venture Management LLC

Former Executive Vice President & Head-Research & Development at Arsenal Biosciences, Inc.

Managing Partner at CTI Capital, Inc.

Director, Chief Executive Officer & President at AVEO Pharmaceuticals Inc.

Chief Financial & Operating Officer at Goldfinch Bio, Inc.

Paths to IMV, Inc.
Potential Connections via
Relationship Science
You
IMV, Inc.
Owners & Shareholders
Details Hidden

VHCP Management focuses on investments in the stocks of US and European small-cap companies in the health technology sector.

Details Hidden

First City Capital manages equity only, fixed income only, and balanced portfolios. For most clients they emphasize a balanced portfolio approach. The firm allocates assets among stocks, bonds, and cash reserves on a discretionary basis in accordance with the client’s designated investment objectives. Their equity style focuses primarily on selecting companies that have growth at a reasonable price (GARP). Special emphasis is placed on analyzing a company's financial strength, its operating exposure to international markets, as well as its long-term strategic goals. First City Capital’s fixed income management aims to satisfy income requirements and to reduce overall portfolio risk and volatility. Their approach is value oriented with issue selection focusing upon the identification of inefficiencies in the market sectors, as well as inconsistencies along the yield curve. In implementing this strategy, the firm maintains a strong preference for quality and liquidity.

Details Hidden

First City Capital manages equity only, fixed income only, and balanced portfolios. For most clients they emphasize a balanced portfolio approach. The firm allocates assets among stocks, bonds, and cash reserves on a discretionary basis in accordance with the client’s designated investment objectives. Their equity style focuses primarily on selecting companies that have growth at a reasonable price (GARP). Special emphasis is placed on analyzing a company's financial strength, its operating exposure to international markets, as well as its long-term strategic goals. First City Capital’s fixed income management aims to satisfy income requirements and to reduce overall portfolio risk and volatility. Their approach is value oriented with issue selection focusing upon the identification of inefficiencies in the market sectors, as well as inconsistencies along the yield curve. In implementing this strategy, the firm maintains a strong preference for quality and liquidity.

Recent Transactions
Details Hidden

IMV, Inc. issued CAD Common Shares - Bought Deal

Details Hidden

IMV, Inc. issued . CAD Common Shares - Bought Deal

Details Hidden

IMV, Inc. issued CAD Units

Transaction Advisors
Escrow Agent

Advised onIMV, Inc. issued CAD Common Shares - Bought Deal

Underwriter

Advised onIMV, Inc. issued CAD Common Shares - Bought Deal

Underwriter

Advised onIMV, Inc. issued . CAD Common Shares - Bought Deal

Associate

Advised onIMV, Inc. issued CAD Common Shares - Bought Deal

Legal Advisor

Advised onIMV, Inc. issued CAD Common Shares - Bought Deal

Advisors & Consultants
Legal Advisor

Partner, Palo Alto at Cooley LLP

Advisor

Chief Financial Officer at IMV, Inc.

Consultant

Co-Founder at Light Sciences Oncology, Inc.

Clients

Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Key Stats and Financials As of 2020
Market Capitalization
$133M
Total Enterprise Value
$153M
Earnings Per Share
$-0.45
EBITDAMargin
-1.48M%
Enterprise Value / Sales
66.1Kx
TEVNet Income
-5.69x
Debt TEV
0.05x
Revenue
$2,300
Net Profit
$-26.9M
EBITDA
$-34.1M
Total Debt
$7.85M
Total Equity
$30.4M
Suppliers
Vlaams Instituut Voor Biotechnologie - Flanders Institute Accounting & Financial Services | Ghent, Belgium

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

Merck KGaA Hospitals & Patient Services | Darmstadt, Germany

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AstraZeneca Plc Pharmaceuticals - Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by IMV, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of IMV, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and IMV, Inc..